Therapeutic use of the substituted pyrimidine, KP544, as a potential pharmacotherapy for the 3-nitropropionic acid mouse model of Huntington's disease

R Myers, Gary Dunbar

Research output: Other contribution

Original languageEnglish
StatePublished - Apr 20 2005

Fingerprint

Dive into the research topics of 'Therapeutic use of the substituted pyrimidine, KP544, as a potential pharmacotherapy for the 3-nitropropionic acid mouse model of Huntington's disease'. Together they form a unique fingerprint.

Cite this